Lithotripsy Devices Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Extracorporeal Shock Wave Lithotripsy Devices, Intracorporeal Lithotripsy Devices), By Application (Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones), By End-User (Hospitals, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F

Market Overview

The Global Lithotripsy Devices Market, valued at USD 2.81 Billion in 2024, is projected to experience a CAGR of 4.96% to reach USD 3.76 Billion by 2030. Lithotripsy devices are medical instruments designed to fragment calculi, such as kidney or bile duct stones, within the body using methods like shock waves or lasers, thereby facilitating their non-surgical removal or natural passage. The market's growth is primarily supported by the increasing global prevalence of urolithiasis, an aging population more susceptible to stone formation, and the expanding adoption of minimally invasive treatment modalities due to enhanced patient outcomes. According to the Urologic Diseases in America Annual Data Report 2024, the claims-based prevalence of urinary stone disease among persons aged 65 and older was 3-5% annually from 2012 to 2021, indicating a significant patient demographic.

Despite these drivers, a significant challenge impeding market expansion is the high capital cost associated with acquiring and maintaining advanced lithotripsy equipment, particularly in developing regions with constrained healthcare budgets. Furthermore, while the market is growing, according to the Urologic Diseases in America Annual Data Report 2024, the utilization of extracorporeal shock wave lithotripsy declined from 9% to 6% among patients aged 18-64 and from 5% to 3% among those aged 65 and older between 2012 and 2021. This suggests that despite overall market growth, specific segments or procedures within lithotripsy face evolving treatment preferences or efficacy considerations.

Key Market Drivers

The escalating prevalence of urolithiasis and kidney stones is a significant driver for the global lithotripsy devices market, creating sustained demand for effective stone management solutions. Influenced by dietary habits, lifestyle shifts, and genetic factors, the patient population requiring intervention remains substantial. According to "Prevalence, Incidence, and Determinants of Kidney Stones in a Nationally Representative Sample of US Adults" in ResearchGate, published September 2025, the prevalence of kidney stones was 11.0% among US adults, underscoring a critical and expanding demographic. Concurrently, technological advancements in lithotripsy devices are transforming treatment options, favoring less invasive and more efficient procedures. Innovations like non-invasive ultrasound-based systems are enhancing patient outcomes and broadening treatment accessibility. For example, according to *The Journal of Urology*, October 2024, "Break Wave Lithotripsy for Urolithiasis: Results of the First-in-Human International Multi-Institutional Clinical Trial," any stone fragmentation was achieved in 88% of patients using Break Wave™ lithotripsy, demonstrating improved fragmentation success rates and quicker recovery.

The combined impact of increasing disease burden and advanced treatment modalities profoundly shapes the lithotripsy devices market. This dynamic encourages ongoing product innovation and the broader adoption of sophisticated systems worldwide. Leading medical device manufacturers actively contribute to this expansion. For instance, according to Boston Scientific's Q3 2024 Financial & Operational Highlights, released October 23, 2024, its Urology sales segment experienced 10% growth, reflecting robust commercial performance fueled by these foundational market drivers and the imperative to deliver improved patient care solutions.

Download Free Sample Report

Key Market Challenges

The high capital cost associated with acquiring and maintaining advanced lithotripsy equipment significantly impedes the growth of the Global Lithotripsy Devices Market. This challenge is particularly pronounced in developing regions, where healthcare budgets are often constrained. The substantial initial investment required for these sophisticated machines, coupled with ongoing maintenance expenses, presents a considerable barrier for hospitals and healthcare providers, limiting their ability to upgrade existing technology or expand their service offerings.

Furthermore, the limited public health expenditure in these regions exacerbates the issue of high capital costs for medical devices. According to the World Health Organization (WHO), in its 2024 Global Spending on Health report, 43 percent of all health spending was out of pocket in low-income countries in 2022, compared to 19 percent in high-income countries. This indicates a substantial financial burden on individuals, which can indirectly affect the willingness or capacity of healthcare systems to invest in expensive equipment. Additionally, according to World Bank documents and reports, the average real annual growth rate of government health spending per capita in low-income countries was only 0.4 percent from 2019 to 2023, with lower-middle income countries seeing a modest 0.9 percent over the same period. This stagnant growth in public funding directly restricts capital allocation for advanced medical technologies, including lithotripsy devices.

Key Market Trends

A growing preference for minimally invasive and outpatient procedures is significantly shaping the global lithotripsy devices market, driven by patient demand for reduced recovery times and healthcare system objectives for cost efficiency. These procedures minimize patient discomfort, lower infection risks, and facilitate quicker returns to daily activities, moving away from more invasive surgical interventions. According to the American Urological Association's 2024 Annual Report, the AUA Quality (AQUA) Registry, which supports data-driven urological care, grew to include over 12 million patients from nearly 2400 providers in 2023, underscoring the collective effort towards enhanced and efficient patient management. This trend encourages manufacturers to develop devices specifically designed for outpatient settings, such as portable and user-friendly systems. For instance, according to "Comparative Efficacy of Digital Flexible Ureteroscopy in Management of" published by RRU on October 15, 2025, a study utilizing flexible ureteroscopy lithotripsy demonstrated a stone-free rate of 87.7% at one month in normal-weight patients, highlighting the effectiveness of these minimally invasive techniques.

The integration of real-time imaging for enhanced precision represents another critical trend, improving both the safety and efficacy of lithotripsy procedures. This advancement allows urologists to visualize stones and surrounding anatomical structures with greater clarity and immediacy during treatment, enabling precise targeting of calculi and minimizing damage to healthy tissues. The American Urological Association, in its 2024 Annual Report, highlighted the AQUA Registry's growth, encompassing over 13.1 million unique patients and more than 106 million patient encounters, reflecting an increasing emphasis on measurable outcomes in urology. Such data-driven approaches reinforce the necessity of technologies that provide intraoperative accuracy. For example, a "Comparison of Extracorporeal Shock Wave Lithotripsy Success Rates Between Ultrasound Targeting and X-ray Targeting" published in DergiPark on September 30, 2023, indicated that the success rate of shock wave lithotripsy using ultrasound targeting was 84%, compared to 72% with X-ray targeting, demonstrating the tangible benefits of real-time imaging in improving treatment outcomes.

Segmental Insights

The Extracorporeal Shock Wave Lithotripsy (ESWL) devices segment stands as the fastest-growing component within the global lithotripsy devices market. This rapid expansion is primarily driven by a pronounced preference for minimally invasive treatment options among both patients and healthcare providers worldwide. ESWL offers significant advantages, including its non-invasive nature which eliminates the need for incisions, leading to reduced patient trauma, shorter hospital stays, and quicker recovery periods compared to traditional surgical interventions. Furthermore, continuous advancements in lithotripsy technology, such as improved imaging and shock wave generation, enhance the efficacy and precision of these procedures, further boosting their adoption for kidney stone management.

Regional Insights

North America holds a leading position in the global lithotripsy devices market due to several key factors. The region experiences a high prevalence of kidney stones and an increasing aging population, driving demand for effective treatments. Its advanced and well-established healthcare infrastructure supports significant healthcare expenditure, fostering a strong environment for technological advancements in lithotripsy devices. Furthermore, there is a pronounced preference for minimally invasive treatment options. Favorable reimbursement policies and a stringent regulatory framework, notably overseen by the Food and Drug Administration (FDA) in the United States, contribute to market confidence and the widespread adoption of high-quality devices, solidifying North America's market dominance.

Recent Developments

• In March 2025, Shockwave Medical, Inc., a Johnson & Johnson MedTech company, introduced its Shockwave Javelin Peripheral IVL Catheter to the U.S. market. This novel intravascular lithotripsy (IVL) platform was specifically engineered to modify calcified lesions and navigate challenging, narrow vessels in patients with peripheral artery disease. The launch of this advanced catheter represents a significant product development, aiming to enhance treatment precision and improve outcomes for patients needing calcification treatment within the global lithotripsy devices market.

• In January 2025, Boston Scientific Corporation entered into a definitive agreement to acquire Bolt Medical, Inc., a company renowned for its intravascular lithotripsy (IVL) laser-based platform. This strategic acquisition aimed to strengthen Boston Scientific's cardiovascular portfolio by integrating Bolt Medical’s innovative technology. The platform is designed to treat calcified coronary and peripheral artery disease by utilizing acoustic pressure waves delivered via balloon catheters, signifying a notable collaboration enhancing offerings in the global lithotripsy devices market.

• In September 2024, breakthrough research highlighted the safety and efficacy of SonoMotion's Break Wave™ lithotripsy (BWL) for treating urinary stones. A clinical trial published in The Journal of Urology demonstrated that this noninvasive ultrasound technology successfully fragmented stones using low-pressure waves. The portable nature of the BWL system allows for treatment in various settings, including outpatient clinics, potentially without the need for anesthesia. This advancement offers a new, less invasive option for managing kidney and ureteral stones within the global lithotripsy devices market.

• In May 2024, Dornier MedTech launched Urogpt, an innovative artificial intelligence (AI) tool designed to assist patients managing kidney stones. Developed in collaboration with urologists, this digital solution provides on-demand advice and actionable insights, aiming to alleviate patient anxieties and inform them about their condition and treatment pathways. This initiative by Dornier MedTech underscores the company's commitment to leveraging digital innovation to enhance personalized care and patient support within the urological care segment of the global lithotripsy devices market.

Key Market Players

• Zimmer MedizinSysteme GmbH
• Olympus Corporation
• Richard Wolf GmbH
• Boston Scientific Corporation
• STORZ Medical AG
• Takara Bio USA, Inc.
• TRINOVA BIOCHEM GmbH
• Upcyte Technologies GmbH

Report Scope:

In this report, the Global Lithotripsy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Lithotripsy Devices Market, By Type:

o   Extracorporeal Shock Wave Lithotripsy Devices

o   Intracorporeal Lithotripsy Devices

• Lithotripsy Devices Market, By Application:

o   Kidney Stones

o   Ureteral Stones

o   Pancreatic Stones

o   Bile Duct Stones

• Lithotripsy Devices Market, By End-User:

o   Hospitals

o   Ambulatory Surgical Centers

o   Others

• Lithotripsy Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Lithotripsy Devices Market.

Available Customizations:

Global Lithotripsy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Lithotripsy Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]